Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Werewolf Therapeutics (HOWL) Equity Average (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Equity Average for 5 consecutive years, with $27.2 million as the latest value for Q4 2025.

  • Quarterly Equity Average fell 66.57% to $27.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27.2 million through Dec 2025, down 66.57% year-over-year, with the annual reading at $49.1 million for FY2025, 46.85% down from the prior year.
  • Equity Average for Q4 2025 was $27.2 million at Werewolf Therapeutics, down from $35.5 million in the prior quarter.
  • The five-year high for Equity Average was $175.4 million in Q3 2021, with the low at $13.9 million in Q2 2021.
  • Average Equity Average over 5 years is $102.0 million, with a median of $114.5 million recorded in 2024.
  • The sharpest move saw Equity Average skyrocketed 868.13% in 2022, then plummeted 66.57% in 2025.
  • Over 5 years, Equity Average stood at $161.0 million in 2021, then fell by 21.36% to $126.6 million in 2022, then fell by 11.63% to $111.9 million in 2023, then fell by 27.28% to $81.4 million in 2024, then tumbled by 66.57% to $27.2 million in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at $27.2 million, $35.5 million, and $49.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.